Deep Genomics hits the partnering ground running with BioMarin deal
Amirah Al Idrus, Fierce Biotech
Jennifer Alsever, Fortune
Computers are sifting through an endless archive of biological data and quickly finding patterns that it would take a human a lifetime to discover.
Amber Tong, Endpoint News
Brendan Frey set out, when he began the project to pick out a lead program for Deep Genomics, to prove that the artificial intelligence systems his lab has designed can identify new drug targets and find a winning candidate much faster than traditional methods.
Ben Adams, FierceBiotech
Canadian drug development company Deep Genomics has got off a $40 million series B round as it looks to double down on its rare genetic disease and artificial intelligence work
Brian Gormley, wsj.com
Deep Genomics Inc. has raised $40 million in venture capital to put treatments discovered through its artificial intelligence-based drug-discovery platform to the test in human studies.
Sydney Loney, National Post
'For the first time in human history, our ability to collect data on our biology has outpaced our ability to interpret and act on it'